Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

Open Label ◽

Phase 3 ◽

Reduced Intensity ◽

Faculty Opinions recommendation of Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958906.793462914 ◽

2012 ◽

Author(s):

Nelson Chao

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Open Label ◽

Phase 3 ◽

Reduced Intensity ◽

Faculty Opinions recommendation of Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958906.793464270 ◽

2012 ◽

Author(s):

Anskar YH Leung

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Open Label ◽

Phase 3 ◽

Reduced Intensity ◽

Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial

The Lancet Haematology ◽

10.1016/s2352-3026(18)30022-x ◽

2018 ◽

Vol 5 (4) ◽

pp. e161-e169 ◽

Cited By ~ 21

Author(s):

Frederick Fasslrinner ◽

Johannes Schetelig ◽

Andreas Burchert ◽

Michael Kramer ◽

Rudolf Trenschel ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Open Label ◽

Myeloablative Conditioning ◽

Phase 3 ◽

Reduced Intensity ◽

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(20)30455-1 ◽

2020 ◽

Vol 21 (9) ◽

pp. 1201-1212 ◽

Cited By ~ 5

Author(s):

Li Xuan ◽

Yu Wang ◽

Fen Huang ◽

Zhiping Fan ◽

Yajing Xu ◽

...

Keyword(s):

Stem Cell ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Stem Cell Transplantation ◽

Haematopoietic Stem Cell ◽

Open Label ◽

Phase 3 ◽

Faculty Opinions recommendation of Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726774118.793548561 ◽

2018 ◽

Author(s):

Stephen Nimer

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Cell ◽

Allogeneic (Allo) Stem Cell Transplantation (SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1) with a Reduced Intensity Conditioning (RIC) of Fludarabine (Flu), 2 Day Busulfan (Bu2) and Horse ATG (hATG): The UMass Experience

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.12.248 ◽

2014 ◽

Vol 20 (2) ◽

pp. S156-S157

Author(s):

Rajneesh Nath ◽

Jan Cerny ◽

Muthalagu Ramanathan ◽

Glen Raffel ◽

Mridula George ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Complete Remission ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Reduced Intensity ◽

Haematopoietic cell transplantation with and without sorafenib maintenance for patients withFLT3-ITD acute myeloid leukaemia in first complete remission

British Journal of Haematology ◽

10.1111/bjh.14260 ◽

2016 ◽

Vol 175 (3) ◽

pp. 496-504 ◽

Cited By ~ 99

Author(s):

Andrew M. Brunner ◽

Shuli Li ◽

Amir T. Fathi ◽

Martha Wadleigh ◽

Vincent T. Ho ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Haematopoietic Cell ◽

Outpatient reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukaemia in children

British Journal of Haematology ◽

10.1111/j.1365-2141.2010.08353.x ◽

2010 ◽

Vol 151 (2) ◽

pp. 200-202

Author(s):

Laura Rodríguez-Romo ◽

Consuelo Mancias-Guerra ◽

Oscar González-Llano ◽

José Carlos Jaime-Pérez ◽

Sylvia Martínez-Cabriales ◽

...

Keyword(s):

Stem Cell ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Reduced Intensity ◽

Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes

British Journal of Haematology ◽

10.1111/j.1365-2141.2007.06676.x ◽

2007 ◽

Vol 138 (4) ◽

pp. 517-526 ◽

Cited By ~ 32

Author(s):

Zi Yi Lim ◽

Laurence Pearce ◽

Aloysius Y. Ho ◽

Linda Barber ◽

Wendy Ingram ◽

...

Keyword(s):

Stem Cell ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cell Transplantation ◽

Myelodysplastic Syndromes ◽

Improved Outcomes ◽

Reduced Intensity ◽

Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation

Leukemia Research ◽

10.1016/j.leukres.2009.10.028 ◽

2010 ◽

Vol 34 (6) ◽

pp. 723-727 ◽

Cited By ~ 59

Author(s):

Z.Y. Lim ◽

V. Fiaccadori ◽

S. Gandhi ◽

J. Hayden ◽

M. Kenyon ◽

...

Keyword(s):

Stem Cell ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Myelodysplastic Syndromes ◽

Haematopoietic Stem Cell Transplantation ◽

Haematopoietic Stem Cell ◽

Reduced Intensity ◽